In line with our observations, MUC1 was previously reported to associate with therapy resistance in several other cancer types, such as breast cancer31 and pancreatic cancer.32 Of note is that the MUC1 expression was relatively low in untreated or naïve tumors but significantly induced by PTX, pro-longed treatment in particular. Here, MUC1 is linked to cancer.